NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced today that Barry Weiner, President, will make a presentation at the UBS 2008 Global Life Sciences Conference at the Grand Hyatt Hotel in New York City, on Tuesday, September 23, 2008, at 10:00 A.M. (E.T.)
